Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Mali
Clinical trial NCT00889616 · COMPLETED
Trial details
- NCT number
- NCT00889616
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-23
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.